本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

201.79
-1.9850-0.97%
成交量:3.88萬
成交額:785.76萬
市值:432.50億
市盈率:-22.62
高:203.98
開:203.50
低:201.01
收:203.77
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:1.13
換手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.59
市盈率(LYR):-33.91

資料載入中...

2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities